Within the MERIT Clinical Trials team, we see our Project Management (PM) division as the central hub, serving as the primary point of contact for both internal and external stakeholders, including sponsors, vendors, and sites, among others....
Article
At MERIT, we recognize that every client holds a unique position of importance, with distinct studies, approaches, and endpoints. Our dedicated team ensures that this individuality is acknowledged and leveraged to deliver exceptional services tailored to our clients’ specific wants and needs....
Article, Clinical Endpoint ExpertsAug 09, 2023
4 Reasons to Partner with a Respiratory Clinical Endpoint Expert
Discover 4 reasons to partner with a clinical endpoint expert for your next respiratory trial....
Learn five facts about the current state of clinical trials including details about trial costs, enrollment issues, and the difficulty and complexity of today's studies....
Article, OncologyJun 21, 2023
Treating Lung Cancer with Antibody-Drug Conjugates: Advancing Clinical Trials
Given that the relative survival rate of patients diagnosed with metastatic lung cancer is low, and that traditional chemotherapy and surgery are of limited efficacy, ADCs represent a potentially important treatment option....
ArticleJun 01, 2023
Validating Your Imaging Data to Secure Funding: Collect and Hold MERIT Webinar Takeaways
MERIT’s most recent webinar provided an interactive Q & A style session discussing how early phase centralized image storage can help sponsors secure funding. ...
Our ophthalmology case studies illustrate how we seamlessly manage the imaging components of your trial, creating efficiencies for your drug development. ...
ArticleApr 03, 2023
Geographic Atrophy Treatments
This article provides a brief overview of Geographic Atrophy (GA) treatments under development....
MERIT’s respiratory case studies demonstrate that our quality overreads, fast turnaround times, and easy-to-reach RTs will help you move your trial forward....
You need a partner that not only delivers access to a deep bench of SMEs and a secure imaging platform, but also has the clinical operations experience to drive study milestone achievement....
Article, OphthalmologyFeb 28, 2023
First Anti-VEGF Treatment Approved for Retinopathy of Prematurity
ROP is one of the leading causes of childhood blindness globally. The availability of an FDA approved medication for ROP represents an important alternative for preterm infants and their parents...
Article, OncologyFeb 13, 2023
PCWG3 and Oncology Endpoints Webinar Summary PCWG3 and PSMA PET/CT Response Criteria
Learn more about the fundamentals of PCWG3 response criteria, PSMA PET/CT response criteria, data collection, and response assessment....